[1]张金富,周细妹.质子泵抑制剂联合铝镁加混悬液治疗胃内镜黏膜溃疡的临床价值[J].医学信息,2024,37(07):127-130.[doi:10.3969/j.issn.1006-1959.2024.07.025]
　ZHANG Jin-fu,ZHOU Xi-mei.Clinical Value of Proton Pump Inhibitor Combined with Aluminum Magnesium Suspension in the Treatment of Gastric Endoscopic Mucosal Ulcer[J].Journal of Medical Information,2024,37(07):127-130.[doi:10.3969/j.issn.1006-1959.2024.07.025]
点击复制

质子泵抑制剂联合铝镁加混悬液治疗胃内镜黏膜溃疡的临床价值()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
37卷
期数:
2024年07期
页码:
127-130
栏目:
论著
出版日期:
2024-04-01

文章信息/Info

Title:
Clinical Value of Proton Pump Inhibitor Combined with Aluminum Magnesium Suspension in the Treatment of Gastric Endoscopic Mucosal Ulcer
文章编号:
1006-1959（2024）07-0127-04
作者:
张金富; 周细妹
（上饶市广信区第五人民医院/上饶市广信区妇幼保健院内科，江西 上饶 334100）
Author(s):
ZHANG Jin-fu; ZHOU Xi-mei
(Department of Internal Medicine,the Fifth People’s Hospital of Guangxin District/Maternal and Child Health Hospitalof Guangxin District,Shangrao 334100,Jiangxi,China)
关键词:
质子泵抑制剂; 铝镁加混悬液; 胃内镜黏膜溃疡
Keywords:
Proton pump inhibitor; Aluminum magnesium suspension; Gastric endoscopic mucosal ulcer
分类号:
R975
DOI:
10.3969/j.issn.1006-1959.2024.07.025
文献标志码:
A
摘要:
目的 研究质子泵抑制剂联合铝镁加混悬液治疗胃内镜黏膜溃疡的疗效。方法 选取2021年1月-2022年12月我院诊治的80例胃内镜黏膜溃疡患者为研究对象，采用随机数字表法分为对照组和观察组，各40例。对照组采用质子泵抑制剂治疗，观察组在对照组基础上联合铝镁加混悬液治疗，比较两组临床疗效、延迟性出血发生率、溃疡面积、消化道症状评分（GSRS）、不良反应发生率。结果 观察组治疗总有效率为95.00%，高于对照组的80.00%（P＜0.05）；观察组延迟性出血发生率为5.00%，低于对照组的12.50%（P＜0.05）；观察组治疗2、4周后溃疡面积小于对照组，GSRS评分低于对照组（P＜0.05）；观察组不良反应发生率与对照组比较，差异无统计学意义（P＞0.05）。结论 质子泵抑制剂联合铝镁加混悬液可提高胃内镜黏膜溃疡的治疗效果，减轻胃肠道症状，降低延迟性出血发生率，缩小溃疡面积，且不会增加不良反应，应用安全性较高。
Abstract:
Objective To study the effect of proton pump inhibitor combined with aluminum magnesium suspension in the treatment of gastric endoscopic mucosal ulcer.Methods A total of 80 patients with gastric endoscopic mucosal ulcer diagnosed and treated in our hospital from January 2021 to December 2022 were selected as the research objects. They were divided into control group and observation group by random number table method, with 40 patients in each group. The control group was treated with proton pump inhibitors, and the observation group was treated with aluminum magnesium plus suspension on the basis of the control group. The clinical efficacy, incidence of delayed bleeding, ulcer area, gastrointestinal symptom score (GSRS), and incidence of adverse reactions were compared between the two groups.Results The total effective rate of treatment in the observation group was 95.00%, which was higher than 80.00% in the control group (P<0.05). The incidence of delayed bleeding in the observation group was 5.00%, which was lower than 12.50% in the control group (P<0.05). After 2 and 4 weeks of treatment, the ulcer area of the observation group was smaller than that of the control group, and the GSRS score was lower than that of the control group (P<0.05). There was no significant difference in the incidence of adverse reactions between the observation group and the control group (P>0.05).Conclusion Proton pump inhibitor combined with aluminum magnesium suspension can improve the therapeutic effect of gastric endoscopic mucosal ulcer, reduce gastrointestinal symptoms, the incidence of delayed bleeding and the ulcer area, and will not increase adverse reactions, the application safety is high.

参考文献/References:

[1]周婉,陈晶,韩树堂,等.乌芍散联合质子泵抑制剂治疗胃内镜黏膜下剥离术术后溃疡的临床研究[J].中国中西医结合消化杂志,2021,29(8):540-544,549.[2]张潇雨,程亚男,巩小琳.胃内镜下黏膜剥离术后联合应用康复新液与奥美拉唑的效果观察[J].中国实用医刊,2020,47(11):98-101.[3]祝沛沛,刘梁英,彭雷,等.康复新液联合奥美拉唑治疗胃黏膜剥离术后并发症的疗效研究[J].重庆医学,2019,48(5):807-810,813.[4]严海荣,严苏,李锐,等.早期胃癌内镜黏膜下剥离术后迟发性出血风险预测评分系统的研究[J].南京医科大学学报,2021,41(9):1348-1353.[5]卢桂芳,杨佳卉,卢新兰,等.局部喷洒铝镁加混悬液对上消化道ESD术后溃疡的治疗作用[J].西安交通大学学报(医学版),2020,41(4):588-592.[6]中华医学会消化内镜学分会,中国抗癌协会肿瘤内镜专业委员会.中国早期胃癌筛查及内镜诊治共识意见(2014年,长沙)[J].中华消化内镜杂志,2014,31(7):361-377.[7]王雪艳,张旭东,潘海洋.康复新液联合四联疗法治疗幽门螺旋杆菌阳性胃溃疡的临床研究[J].现代药物与临床,2021,36(8):1613-1618.[8]陈明.内镜下金属夹止血联合胃黏膜肾上腺素治疗溃疡性上消化道出血的疗效及对止血成功率的影响[J].山西医药杂志,2021,50(5):813-815.[9]苏颜平,赵瑞.艾普拉唑联合康复新液治疗胃溃疡临床疗效观察[J].山西医药杂志,2020,49(18):2498-2500.[10]杨丽,苏德望,朱艳丽,等.内镜黏膜下剥离术对胃肠道间质瘤患者细胞免疫功能及胃肠激素的影响[J].广东医学,2019,40(2):242－245.[11]石晓蕾.云南白药联合艾司奥美拉唑治疗消化性溃疡并出血的疗效观察[J].中国中西医结合消化杂志,2020,28(11):894-895.[12]金雷,李蜀豫,代凤玲,等.艾普拉唑四联疗法联合双歧杆菌在幽门螺杆菌补救方案中的疗效评价［J］.世界华人消化杂志,2018,26(4):256-262.[13]李艳艳.聚普瑞锌治疗内镜黏膜下剥离术术后溃疡一例报告[J].北京医学,2022,10(4):24-26.[14]王维,潘帆帆,聂伟杰.内镜特征对早期胃癌患者内镜黏膜下层剥离术后溃疡发生风险的预测价值[J].中国中西医结合消化杂志,2022,30(2):85-89.[15]黄志豪,林梓瀚,李静慧.质子泵抑制剂联合铝镁加混悬液治疗胃内镜黏膜下剥离术术后溃疡的临床价值[J].医学理论与实践,2023,36(3):419-421.[16]张静.铝碳酸镁和艾司奥美拉唑及幽门螺杆菌根治方案联合治疗胃溃疡的效果分析[J].中国药物经济学,2018,13(12):59-61.[17]杨瑞琦,毛华,黄丽韫,等.铝碳酸镁联合艾司奥美拉唑治疗胃溃疡黏膜愈合质量的临床研究[J].中华消化杂志,2017,37(1):35-40.[18]张少君,董小林.PPI联合瑞巴派特促进内镜黏膜下剥离术术后溃疡愈合的疗效分析[J].胃肠病学和肝病学杂志,2017,20(6):113-115.[19]曾圆.艾司奥美拉唑联合莫沙必利和铝镁加混悬液治疗反流性食管炎疗效观察[J].天津药学,2022,34(2):47-50.

相似文献/References:

[1]冯曲波,颜 婷,伍国林.2014年~2016年我院质子泵抑制剂应用分析[J].医学信息,2018,31(08):116.[doi:10.3969/j.issn.1006-1959.2018.08.039]
　FENG Qu-bo,YAN Ting,WU Guo-lin.Application of Proton Pump Inhibitors in our Hospital from 2014 to 2016[J].Journal of Medical Information,2018,31(07):116.[doi:10.3969/j.issn.1006-1959.2018.08.039]
[2]毕月玲,潘丽华,闫永悦.2017年第一、二季度我院口服质子泵抑制剂 应用情况分析[J].医学信息,2018,31(10):119.[doi:10.3969/j.issn.1006-1959.2018.10.038]
　BI Yue-ling,PAN Li-hua,YAN Yong-yue.Application of Oral Proton Pump Inhibitors in our Hospital in the First,Second Quarter of 2017[J].Journal of Medical Information,2018,31(07):119.[doi:10.3969/j.issn.1006-1959.2018.10.038]
[3]何志钧,梁运啸,梁列新.质子泵抑制剂治疗上消化道出血对痛风复发的影响[J].医学信息,2019,32(01):154.[doi:10.3969/j.issn.1006-1959.2019.01.048]
　HE Zhi-jun,LIANG Yun-xiao,LIANG Lie-xin.Effect of Proton Pump Inhibitor on Upper Gastrointestinal Hemorrhage on Recurrence of Gout[J].Journal of Medical Information,2019,32(07):154.[doi:10.3969/j.issn.1006-1959.2019.01.048]
[4]桑腮芳.胃黏膜保护剂联合质子泵抑制剂治疗消化性溃疡伴出血的临床效果[J].医学信息,2024,37(02):149.[doi:10.3969/j.issn.1006-1959.2024.02.031]
　SANG Sai-fang.Clinical Effect of Gastric Mucosal Protective Agent Combined with Hydrogen Pump Inhibitors in the Treatment of Peptic Ulcer Bleeding[J].Journal of Medical Information,2024,37(07):149.[doi:10.3969/j.issn.1006-1959.2024.02.031]

更新日期/Last Update: 1900-01-01